Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Dec 17, 2008

Premium
Daniel Nevrivy, a Washington, DC, patent attorney, has launched Nevrivy Patent Law Group, a law firm focused on biotechnology and pharmaceutical patent law for businesses, universities, and inventors.
 
The new firm will be located in the Georgetown area of Washington, DC. Nevrivy was formerly with the DC firm of Sterne, Kessler, Goldstein, and Fox for seven years. He holds a PhD in molecular and cellular biology.
 
Nevrivy said in a statement that he is currently building a team of lawyer-scientists to “serve businesses, universities, and inventors who seek innovative ways to lower their costs for protection of their own IP without sacrificing quality.”
 

 
The Association of University Research Parks last week elected Gregory Deason, director of the Purdue Research Park, as president of the organization.
 
Deason’s appointment was announced at AURP’s annual meeting in St. Petersburg, Fla.
 
In addition, AURP elected four new members and re-elected two individuals to its board of directors.
 
The new members are Kevin Bryne, chief investment officer with the University Financing Foundation in Atlanta; Reynold Gonzales, director of technology transfer at the Institute of Innovation and Technology Transfer of Nuevo Leon, Mexico, and director of the Parque de Investgacion e Innovacion Tecnnologica; Marcia Mellitz, president and CEO of the Center for Emerging Technologies in St. Louis, Mo.; and Scott Pickard, manager of Research Park and Incubation Facilities for the University of Illinois in Champaign.
 
The re-elected board members are Brian Darmondy, associate vice president of research and economic development at the University of Maryland; and Teresa McKnight, CEO of the South Dakota State University Growth Partnership and executive director of the South Dakota State University Innovation Campus.
 

 
The Foundation for the National Institutes of Health said last week that it has named five new directors: Anne Wojcicki, co-founder of 23andMe; Pfizer Chief Medical Officer Joseph Feczko; Peter Neupert, corporate vice president of the Health Solutions Group at Microsoft; Kurt Schmoke, dean of Howard University School of Law; and Samuel Thier, professor emeritus, medicine and health care policy at Harvard Medical School and Massachusetts General Hospital.

The appointments were effective as of Nov. 12, 2008.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.